Patents by Inventor Douglas Sammond

Douglas Sammond has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors
    Publication number: 20080051395
    Abstract: The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
    Type: Application
    Filed: December 6, 2005
    Publication date: February 28, 2008
    Inventors: David Uehling, Kirk Stevens, Scott Dickerson, Alex Waterson, Philip Harris, Douglas Sammond, Robert Hubbard, Holly Emerson, Joseph Wilson
  • Novel Diazepine Compounds as Ligands of the Melanocortin 1 and/or 4 Receptors
    Publication number: 20070270411
    Abstract: There is provided novel diazepines that function as agonists at the melanocortin 4 receptor and as agonists at the melanocortin 1 receptor, pharmaceutical compositions containing them, methods for their use in treatment, and processes for their preparation.
    Type: Application
    Filed: May 27, 2005
    Publication date: November 22, 2007
    Inventors: Jerzy Szewczyk, Jason Speake, Douglas Sammond, Ronald Sherrill
  • Diamino-pyrimidines and their use as angiogenesis inhibitors
    Publication number: 20050234083
    Abstract: Benzimidazole derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such benzimidazole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: February 28, 2003
    Publication date: October 20, 2005
    Inventors: Stanley Chamberlain, Mui Cheung, Holly Emerson, Neil Johnson, Kristen Nailor, Douglas Sammond, Marcus Semones
  • Pyrimidine compounds
    Publication number: 20050085637
    Abstract: Pyrimidine derivatives, which are useful as TIE-2 and/or VEGFR-2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: February 7, 2003
    Publication date: April 21, 2005
    Inventors: Mui Cheung, Kristen Nailor, Douglas Sammond, James Veal